at the last shareholder conference call the CEO said he was talking to parties re a placement as they would need the funds to market the product; the sp was approx 9c then.
- Forums
- ASX - By Stock
- ADR
- Adherium receives US FDA 510k OTC clearance
Adherium receives US FDA 510k OTC clearance, page-31
Featured News
Add ADR (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.585M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $1 | 118 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 1059944 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 124294 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 1709944 | 0.009 |
6 | 1944995 | 0.008 |
6 | 1434500 | 0.007 |
2 | 798333 | 0.006 |
3 | 699996 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 637556 | 2 |
0.012 | 381200 | 3 |
0.013 | 500 | 1 |
0.016 | 50000 | 1 |
0.017 | 532838 | 3 |
Last trade - 10.00am 18/11/2024 (20 minute delay) ? |
Featured News
ADR (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online